Composition: Each uncoated tablet contains Lorazepam BP 1 mg, Lorazepam BP 2 mg or Lorazepam USP 2 mg, according to product variant.
Brand: Lozepam 1 / Lozepam 2
Usage: Prescription management of anxiety and selected anxiety-related sleep problems.
Category: Anti Anxiety Drugs
Therapeutic category: Benzodiazepine / Anxiolytic
SKU: Lorazepam Tablets
Categories: Pharmaceutical Exporter India, Pharmaceutical Formulations India, WHO GMP Certified Formulations
Prescription / controlled medicine: Supply subject to applicable law and authorisations.
Lorazepam Tablets/ (Lozepam) is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.
For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.
Lorazepam Tablets contain a prescription benzodiazepine used for short-term management of anxiety disorders and anxiety-associated insomnia where clinically appropriate. The supplied product range lists Lozepam 1 (BP 1 mg) and Lozepam 2 (BP or USP 2 mg), as uncoated tablets.
Manufacturer listed: Healthy Life Pharma Pvt. Ltd. Exporter listed: Healthy Inc. Psychotropic manufacturing/export licences, WHO-GMP status and supply arrangements must be independently verified before publication.
| Product Name | Lorazepam Tablets |
|---|---|
| Brand | Lozepam 1 / Lozepam 2 |
| Active ingredient | Lorazepam BP 1 mg; Lorazepam BP 2 mg; Lorazepam USP 2 mg |
| Dosage form | Uncoated tablet |
| CAS number | 846-49-1 |
| Therapeutic class | Benzodiazepine / anxiolytic |
| Strengths confirmed by supplied labels | 1 mg and 2 mg |
| Other strengths | 0.5 mg mentioned in descriptive copy only; availability unverified |
| Packaging / shelf life | Confirm with approved product label and stability data |
| Regulatory status | Prescription / controlled medicine; country-specific requirements |
Low-dose benzodiazepine tablets require validated processes for blending, uniformity of dosage units, compression and prevention of cross-contamination. Controlled-substance handling also requires appropriate security, inventory reconciliation, authorised personnel and recordkeeping.
Specific granulation methods, equipment, security systems and licensing claims must be substantiated with current manufacturing and regulatory documentation.
Appropriate tests include identity, assay, dosage-unit uniformity, dissolution, related substances, packaging integrity and stability according to the registered product specification. Exact numerical release limits and shelf-life claims should be verified against applicable BP/USP monographs, approved specifications and batch data.
Lorazepam enhances the inhibitory effects of gamma-aminobutyric acid (GABA) at GABA-A receptors. It may be prescribed for short-term relief of severe anxiety and selected anxiety-related sleep problems; some formulations or settings also involve procedural premedication under medical supervision.
Although lorazepam has no major active metabolites and undergoes glucuronidation, it is not automatically safe for older adults or patients with liver disease. Sedation, confusion and falls remain important risks.
Lorazepam is subject to psychotropic or controlled-medicine rules in many jurisdictions. Manufacture, possession, distribution, import and export may require specific authorisations and permits from competent authorities. Request verified licences, approved product registration, certificates of analysis and destination-country import permissions before any transaction. Do not assume export eligibility or WHO-GMP certification from promotional copy.
Q: What strengths are listed?
A: Lozepam 1 contains lorazepam BP 1 mg; Lozepam 2 is listed with lorazepam BP or USP 2 mg.
Q: Is it the same as Ativan?
A: Ativan is a lorazepam brand. Equivalence or bioequivalence of a particular product must be supported by applicable approval records.
Q: Can lorazepam cause dependence?
A: Yes. Abuse, misuse, addiction, physical dependence and potentially serious withdrawal reactions are known risks.
Q: Can it be taken with alcohol or opioid pain medicines?
A: Combining them can cause profound sedation, respiratory depression, coma or death. Avoid alcohol and consult the prescriber about all medicines.
Dosage and treatment duration must be individualised by the prescribing clinician based on indication, age, other medicines and health status. Use the lowest effective dose for the shortest appropriate duration. Do not stop abruptly after regular use; a clinician may need to supervise gradual tapering to reduce withdrawal and seizure risks.
Take only as directed on the prescription and approved local product label. Do not drive or operate machinery if sedated.
Store in the original, labelled packaging according to the approved product instructions, protected from inappropriate heat, light and moisture. Keep securely locked and inaccessible to children or unauthorised persons. Confirm any specific temperature limit from the registered pack label.